Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹16.36Admitted-Finance CIPLA HOUSE PENINSULA BUSINESS PARK GANPATRAO KADAM MARG LOWER PAREL MUMBAI MAHARASHTRA 400013 | MUMBAI | MAHARASHTRA | 400013 | L1 | Admitted-Finance | |
| 2 | L2₹19.50+₹3.14 (19.2%)Admitted-Finance | L2 | Admitted-Finance | |
| 3 | L3₹20.86+₹4.50 (27.5%)Admitted-Finance | L3 | Admitted-Finance | |
| 4 | L4₹22.44+₹6.08 (37.2%)Admitted-Finance PLOT NO 2117 A 2 PHASE II II G I D C VAPI GUJARAT INDIA 396195 | VAPI | VALSAD | GUJARAT | 396195 | L4 | Admitted-Finance | |
| 5 | L5₹28.16+₹11.80 (72.1%)Admitted-Finance | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Intas Pharmaceuticals ltd L9 | Cipla ltd L1 | Novo Nordisk India Private Limited L10 | MicronPharmaceuticals L4 | Takeda Biopharmaceuticals India Private Limited L7 | ROCHE PRODUCTS (INDIA) PVT. LTD. L11 | SUPERMAX DRUGS & PHARMACEUTICALS P LTD L5 | BDR PHARMACEUTICALS INTERNATIONAL PVT.LTD. L3 | Sun Pharma Laboratories Ltd L6 | Grifols India Healthcare Private Limited L8 | BAJAJ HEALTHCARE LIMITED L2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Anti Hemophilia Factors and Chelation Drugs | ||||||||||||||
| 1.01 | FVIII with vWF 250 IU Plasma Derived | 1 | IU | - | - | - | - | 6.09 ₹6.39 Lowest | - | - | - | - | 1,747 ₹1,834.35 | - |
| 1.02 | Factor VIII 250 IU Recombinant | 1 | IU | - | - | - | - | - | - | - | - | - | - | - |
| 1.03 | Factor VIII 500 IU Recombinant | 1 | IU | - | - | 2,840 ₹2,982 | - | 6.49 ₹6.81 Lowest | - | - | - | - | - | - |
| 1.04 | Factor IX 500 IU Plasma Derived | 1 | IU | - | - | - | - | - | - | - | - | - | - | - |
| 1.05 | Factor IX 600 IU Plasma Derived | 1 | IU | 4,980 ₹5,229 | - | - | - | 8.34 ₹8.76 Lowest | - | - | - | - | - | - |
| 1.06 | Factor IX 500 IU Recombinant | 1 | IU | - | - | - | - | - | - | - | - | - | - | - |
| 1.07 | Factor VII a 1 mg Recombinant | 1 | IU | - | - | 39,310 ₹41,275.5 Lowest | - | - | - | - | - | - | - | - |
| 1.08 | Factor VII a 2 mg Recombinant | 1 | IU | - | - | 78,620 ₹82,551 Lowest | - | - | - | - | - | - | - | - |
| 1.09 | FEIBA 500 units Plasma | 1 | IU | - | - | - | - | 56 ₹58.8 Lowest | - | - | - | - | - | - |
Tender Value
Refer Docs
Closing Date
27 Jul 2023, 12:30 pmClosed
Managing Director
PHSC, 2nd Floor, PSEB building , E-Block, Phase-IX, S.A.S.Nagar
Rate Contract for Haemophilia factors and Thalessemia Drugs
2023_DHFW_105244_1
PHSC/Proc/2023/65
Open Tender
Miscellaneous Goods
Item Rate
30 days
Punjab
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
Exempted
C.R, PHSC
3 Sept 2025
4 Jul 2023
27 Jul 2023
4 Jul 2023
27 Jul 2023
11 Jul 2023
7 Jul 2023
Anti Hemophilia Factors and Chelation Drugs
FVIII with vWF 250 IU Plasma Derived
Factor VIII 250 IU Recombinant
Factor VIII 500 IU Recombinant
Factor IX 500 IU Plasma Derived
Factor IX 600 IU Plasma Derived
Factor IX 500 IU Recombinant
Factor VII a 1 mg Recombinant
Factor VII a 2 mg Recombinant
FEIBA 500 units Plasma
FEIBA 1000 Units Plasma
Long Acting Glycopegylated Factor IX/Nonacog Beta Pegol 500 IU Recombinant
Long Acting Glycopegylated Factor IX/Nonacog Beta Pegol 1000 IU Recombinant
Rurioctocog Alfa Pegylated Recombinant FVIII 250 IU
Rurioctocog Alfa Pegylated Recombinant FVIII 500 IU
Rurioctocog Alfa Pegylated Recombinant FVIII 1000 IU
Turoctocog Alfa Pegol Factor VIII 500 IU Recombinant
Turoctocog Alfa Pegol Factor VIII 1000 IU Recombinant
Emicizumab 30 mg Recombinant
Emicizumab 60 mg Recombinant
Emicizumab 105 mg Recombinant
Emicizumab 150 mg Recombinant
Tablet Deferasirox FCT 90 mg
Tablet Deferasirox FCT 180 mg
Tablet Deferasirox FCT 360 mg
Tablet Deferasirox 250 mg
Tablet Deferasirox 400 mg
Tablet Deferasirox 500 mg
Inj Desferioxamine 500 mg
Capsule Deferiprone 250 mg
BAJAJ HEALTHCARE LIMITED
BDR PHARMACEUTICALS INTERNATIONAL PVT.LTD.
MicronPharmaceuticals
SUPERMAX DRUGS & PHARMACEUTICALS P LTD
Sun Pharma Laboratories Ltd
Takeda Biopharmaceuticals India Private Limited
Grifols India Healthcare Private Limited
Intas Pharmaceuticals ltd
Novo Nordisk India Private Limited
ROCHE PRODUCTS (INDIA) PVT. LTD.
BAJAJ HEALTHCARE LIMITED
Novo Nordisk India Private Limited
Takeda Biopharmaceuticals India Private Limited
SUPERMAX DRUGS & PHARMACEUTICALS P LTD
stage.html
html • 0.04 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .